SS Innovations International, the creator of India’s homegrown surgical robot SSI Mantra, made history on Wednesday by ringing the opening bell at the Nasdaq Market Site in New York City. This landmark event signals a significant achievement for Indian medical technology on the world stage.
The company’s shares are now trading under the ticker symbol ‘SSII’, representing a proud moment for India’s growing influence in advanced medical technologies. Dr. Sudhir Srivastava, Founder, Chairman, and CEO of SS Innovations International, led the ceremony alongside the company’s management team, board members, advisors, and special guests.
The SSI Mantra Surgical Robotic System, developed by SS Innovations, has already made substantial inroads in the healthcare sector. The system is currently installed in 80 hospitals across 75 locations in India. Its reach extends beyond national borders, with presence in countries including Nepal, Ecuador, Guatemala, the Philippines, Indonesia, Sri Lanka, Colombia, and Ukraine.
The robotic system has demonstrated its efficacy through over 4,000 successful surgeries spanning more than 100 different procedures. By offering a cost-effective alternative, SSI Mantra is broadening access to advanced robotic surgery for a wider patient demographic.
This Nasdaq debut not only showcases India’s technological prowess but also heralds a new chapter in the country’s contribution to global healthcare innovation. As SS Innovations International takes its place on the international stock market, it paves the way for greater recognition and adoption of Indian-origin medical solutions worldwide.
